Akash Tewari
Stock Analyst at Jefferies
(0)
# 4116
Out of 5,249 analysts
65
Total ratings
37.14%
Success rate
-4.66%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Bristol-Myers Squibb | Upgrades: Buy | 63 70 | 59.15 | 18.34% | 3 | Dec 16, 2024 | |
Biomarin Pharmaceuti... | Initiates Coverage On: Outperform | 95 | 62.12 | 52.93% | 2 | Nov 15, 2024 | |
BioNTech | Upgrades: Buy | 96 150 | 121.96 | 22.99% | 3 | Sep 17, 2024 | |
Relay Therapeutics | Upgrades: Buy | 11 16 | 4.89 | 227.2% | 3 | Sep 10, 2024 | |
Neurocrine Bioscienc... | Maintains: Strong Buy | 177 189 | 147.39 | 28.23% | 2 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 80 | 30.71 | 160.5% | 2 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 29 75 | 34.42 | 117.9% | 1 | Jul 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 994 1015 | 765.8 | 32.54% | 6 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 50 | 31.7 | 57.73% | 5 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 37 75 | 40 | 87.5% | 4 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 21.67 | 43.05% | 1 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 32 40 | 18.17 | 120.14% | 2 | Dec 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 935 937 | 694.38 | 34.94% | 4 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 12 | 1.96 | 512.24% | 2 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 38 39 | 26.45 | 47.45% | 2 | Oct 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 18 | 5.54 | 224.91% | 2 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 497 513 | 652.38 | -21.36% | 2 | Jul 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 4.64 | 287.93% | 1 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 96.58 | 29.43% | 1 | Mar 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 11 | 14.82 | -25.78% | 1 | Dec 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 4 | 5.8 | -37.93% | 2 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 5.7 | 198.25% | 1 | Dec 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 6 4 | n/a | n/a | 2 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 68 69 | n/a | n/a | 3 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 75 | 47.77 | 57% | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 151 | 339.97 | -55.58% | 1 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 34.16 | -18.03% | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 180 | n/a | n/a | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 107 | n/a | n/a | 1 | Mar 12, 2021 |